Halozyme Therapeutics, Inc. (HALO) forecast

Halozyme Therapeutics, Inc. (HALO) forecast: price $123.57, trailing P/E 35.46, forward P/E 14.34. How to read the street's path.

The live HALO price is $123.57. Trailing P/E is 35.46 and forward P/E is 14.34. The forecast that matters is the earnings path those ratios imply, not a single target price.

A forward P/E below the trailing P/E means the consensus expects earnings to rise. The reverse means the market is looking at a peak. Neither is a schedule. Analyst targets are useful as a range of models. They are not a contract. Discounted cash flow is the long form: cash flows, a discount rate, and a terminal value you can argue with.

Use this page for the HALO forecast URL. The prediction page next to it puts the same live inputs in the price-target framing. Both stay in sync with the quote on the main page.

Learn: Forward P/E · Analyst forecast · DCF

Full HALO quote · Dividends · Price prediction · Academy

Questions